Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02973074 |
Date of registration:
|
22/11/2016 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Oral Iron Substitution for Orthopedic Surgery
|
Scientific title:
|
Pilot Study for Investigation of the Feasibility and for Optimization of Oral Iron Substitution in the Course of Patient Blood Management for Orthopedic Surgery |
Date of first enrolment:
|
November 25, 2016 |
Target sample size:
|
20 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT02973074 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Austria
| | | | | | | |
Contacts
|
Name:
|
Jens Meier, Prof. Dr. |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Kepler University Hospital Linz, Clinic for Anesthesiology and intensive care medicine |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age over 55 years
- indication for patient blood management for elective orthopedic surgery
- listed for a orthopedic surgery (e.g. hip or knee replacement) 5-7 weeks after begin
of patient blood management
- Haemoglobin male < 12-13g/dl, female <11-12g/dl
- written informed consent after written and verbal information
Exclusion Criteria:
- indication for treatment with erythropoietin
- pregnancy
- nursing period
- diarrhea or tendency to diarrhea
- fructose intolerance
- pre - menopause
- permanent or expected blood loss
- participation in other study
- expected compliance problems
- legal incapacity
Age minimum:
55 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Iron Deficiency Anemia
|
Intervention(s)
|
Dietary Supplement: OLEOvital
|
Primary Outcome(s)
|
increase of hemoglobin level
[Time Frame: 4 weeks]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|